Medtronic (NYSE: MDT) reported Q2 EPS of $0.96, in-line with the analyst estimate of $0.96. Revenue for the quarter came in at $4.4 million versus the consensus estimate of $4.37 million.

The company today updated its revenue growth outlook and reiterated its diluted non-GAAP earnings per share (EPS) guidance for fiscal year 2015. In fiscal year 2015, the company now expects revenue growth in the range of 4 to 5 percent on a constant currency basis, which is at the upper end of the company's previously stated range of 3 to 5 percent Medtronic sees FY2015 EPS of $4.00 - $4.10, versus the consensus of $4.05.

For earnings history and earnings-related data on Medtronic (MDT) click here.